Zhengye Biotechnology CFO files initial Form 3

Zhengye Biotechnology Holding Ltd filed an initial Form 3 for Chief Financial Officer Wang Ping.

Accepted by SEC EDGAR 06/25/2026 - 11:39 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Zhengye Biotechnology Holding Ltd filed an initial Form 3 for Chief Financial Officer Wang Ping. This filing establishes Wang Ping as a reporting insider of ZYBT. It does not list any buy, sell, or derivative transactions, and no holdings details appear in the provided data.

Key Figures

Buy transactions reported: 0 transactions Sell transactions reported: 0 transactions Derivative transactions reported: 0 transactions

3 metrics

Buy transactions reported 0 transactions Form 3 transactionSummary buyCount

Sell transactions reported 0 transactions Form 3 transactionSummary sellCount

Derivative transactions reported 0 transactions Form 3 transactionSummary derivativeTransactionCount

Key Terms

Form 3, Chief Financial Officer, reporting person

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Financial Officer financial

""officer_title": "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

reporting person regulatory

""reportingPersons": [ { "name": "Wang Ping (nmn)" } ]"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ZYBT Form 3 filed for Wang Ping represent?

The Form 3 for Wang Ping is an initial statement of beneficial ownership for Zhengye Biotechnology Holding Ltd. It identifies Wang Ping, the Chief Financial Officer, as an insider required to report future transactions and holdings in ZYBT securities.

Did Wang Ping report any ZYBT share transactions on this Form 3?

No transactions are reported on this Form 3 for Wang Ping. The transaction summary shows zero buys, zero sells, zero exercises, and no gifts or restructuring entries, indicating only status as a reporting insider is captured in this filing.

What insider role does Wang Ping hold at Zhengye Biotechnology Holding Ltd (ZYBT)?

Wang Ping is identified as the Chief Financial Officer of Zhengye Biotechnology Holding Ltd. This officer role makes Wang Ping a reporting person under SEC rules, requiring ongoing disclosure of certain ownership and trading activity in ZYBT securities.

Are any derivative securities reported for Wang Ping in the ZYBT Form 3?

No derivative securities appear for Wang Ping in the provided Form 3 data. The derivative summary is empty and the derivativeTransactionCount in the transaction summary is zero, indicating no options, warrants, or similar instruments are listed.

Does the ZYBT Form 3 for Wang Ping show any gifts or tax-withholding transactions?

The Form 3 data for Wang Ping shows no gifts or tax-withholding activity. GiftCount and taxWithholdingCount in the transaction summary are both zero, meaning no such transfers or withholdings are disclosed in this initial ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Ping (nmn)

(Last) (First) (Middle)

NO.1 LIANMENG ROAD

(Street)

JILIN CITY JILIN PROVINCE 132101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/25/2026

3. Issuer Name and Ticker or Trading Symbol
Zhengye Biotechnology Holding Ltd [ ZYBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ping Wang	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)